DNA Methylation Clinical Trial
Official title:
Whether Using DNA Methylome to Select Embryos Can Increase the Live Birth Rate During Assisted Reproductive Technology: A Multicenter, Randomized , Open-label Clinical Trial.
To determine whether using DNA methylome to select embryos can increase the live birth rate.
Status | Recruiting |
Enrollment | 1146 |
Est. completion date | May 31, 2025 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: 1. Women who plan to undergo IVF/ICSI/PGT-A treatment. 2. Women aged 20 years and older. b) Women who obtain 2 or more good-quality blastocysts that defined as morphological score of inner cell mass B or A, trophectoderm C or better, and grade 4 or better on Day 5 of embryo culture. Exclusion Criteria: 4.2 Exclusion Criteria 1. Women with a uterine cavity abnormality, such as a uterine congenital malformation (uterus unicornate, bicornate, or duplex); untreated uterine septum, submucous myoma, or endometrial polyp(s); or with history of intrauterine adhesions. 2. Women who are indicated and planned to undergo preimplantation genetic testing for structural rearrangements (PGT-SR) or preimplantation genetic testing for monogenic (PGT-M). 3. Women who use donated oocytes or sperm to achieve pregnancy; 4. Women with contraindication for assisted reproductive technology or for pregnancy, such as poorly controlled Type I or Type II diabetes; undiagnosed liver disease or dysfunction (based on serum liver enzyme testing); renal disease or abnormal serum renal function; significant anemia; history of deep venous thrombosis, pulmonary embolus, or cerebrovascular accident; uncontrolled hypertension, known symptomatic heart disease; history of or suspected cervical carcinoma, endometrial carcinoma, or breast carcinoma; undiagnosed vaginal bleeding. |
Country | Name | City | State |
---|---|---|---|
China | Center for Reproductive Medicine, Center for Prenatal Diagnosis First Hospital, Jilin University | Changchun | |
China | Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-XIANGYA | Changsha | |
China | 900 th Hospital of Joint Logistics Support Force | Fuzhou | |
China | Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University | Fuzhou | |
China | Guangzhou Womenand Children's Medical Center | Guanzhou | |
China | The Sixth Affiliated Hospital of Sun Yat-sen University | Guanzhou | |
China | Center for Reproductive Medicine, The Affiliated Hospital of Guizhou Medical University | Guiyang | |
China | The first affiliated hospital of Hainan Medical University | Haikou | |
China | Assisted Reproduction Unit, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine | Hangzhou | |
China | The First Affiliated Hospital of Anhui Medical University | Hefei | |
China | Center for Reproductive Medicine, Shandong University | Jinan | |
China | Shandong University | Jinan | Shandong |
China | Affiliated Hospital of Jining Medical University | Jining | |
China | Liuzhou Hospital of Guangzhou Women and Children's Medical Center | Liuzhou | |
China | Department of Reproductive Medicine, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital | Nanjing | |
China | The First Affiliated Hospital with Nanjing Medical University | Nanjing | |
China | Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine,Shanghai Jiao Tong University | Shanghai | |
China | Changhai Hospital | Shanghai | |
China | International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University | Shanghai | |
China | Reproductive Medical Center of Ruijin Hospital, School of Medicine,Shanghai Jiao Tong University | Shanghai | |
China | Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University | Shanghai | |
China | Shenzhen Maternity & Child Healthcare Hospital | Shenzhen | |
China | The Second Hospital of Hebei Medical University | Shijiazhuang | |
China | Center for reproduction and genetics,suzhou municipal hospital | Suzhou | |
China | The General Hospital of Ningxia Medical University | Yinchuan | |
China | Department of Reproductive Medicine, the Third Affiliated Hospital of Zhengzhou University | Zhengzhou | |
China | Reproductive Medical Center, Henan Provincial People's Hospital | Zhengzhou | |
Thailand | Siriraj hospital, Mahidol university | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Shandong University | 900 th Hospital of Joint Logistics Support Force, Changhai Hospital, Fujian Maternity and Child Health Hospital, General Hospital of Ningxia Medical University, Guangzhou Womenand Children's Medical Center, Henan Provincial People's Hospital, International Peace Maternity and Child Health Hospital, Jining Medical University, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Nanjing Maternity and Child Health Care Hospital, RenJi Hospital, Reproductive & Genetic Hospital of CITIC-Xiangya, Ruijin Hospital, ShangHai Ji Ai Genetics & IVF Institute, Shenzhen Maternity & Child Healthcare Hospital, Sir Run Run Shaw Hospital, Siriraj hospital, Mahidol university, Thailand, Sixth Affiliated Hospital, Sun Yat-sen University, Suzhou Municipal Hospital, The Affiliated Hospital Of Guizhou Medical University, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Hainan Medical University, The First Affiliated Hospital with Nanjing Medical University, The First Hospital of Jilin University, The Second Hospital of Hebei Medical University, Third Affiliated Hospital of Zhengzhou University |
China, Thailand,
Brezina PR, Kutteh WH. Clinical applications of preimplantation genetic testing. BMJ. 2015 Feb 19;350:g7611. doi: 10.1136/bmj.g7611. — View Citation
Dahdouh EM, Balayla J, Audibert F; Genetics Committee; Wilson RD, Audibert F, Brock JA, Campagnolo C, Carroll J, Chong K, Gagnon A, Johnson JA, MacDonald W, Okun N, Pastuck M, Vallee-Pouliot K. RETIRED: Technical Update: Preimplantation Genetic Diagnosis — View Citation
Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, Cottone G, Kokocinski F, Michel CE. Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril. 2014 May;101(5):137 — View Citation
Hardarson T, Van Landuyt L, Jones G. The blastocyst. Hum Reprod. 2012 Aug;27 Suppl 1:i72-91. doi: 10.1093/humrep/des230. Epub 2012 Jul 3. No abstract available. — View Citation
Hassold T, Chen N, Funkhouser J, Jooss T, Manuel B, Matsuura J, Matsuyama A, Wilson C, Yamane JA, Jacobs PA. A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet. 1980 Oct;44(2):151-78. doi: 10.1111/j.1469-1809.1980.tb00955.x. — View Citation
Jiang L, Zhang J, Wang JJ, Wang L, Zhang L, Li G, Yang X, Ma X, Sun X, Cai J, Zhang J, Huang X, Yu M, Wang X, Liu F, Wu CI, He C, Zhang B, Ci W, Liu J. Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos. Cell. 2013 May 9;153(4):7 — View Citation
Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012 May 29;13(7):484-92. doi: 10.1038/nrg3230. — View Citation
Kalousek DK, Pantzar T, Tsai M, Paradice B. Early spontaneous abortion: morphologic and karyotypic findings in 3,912 cases. Birth Defects Orig Artic Ser. 1993;29(1):53-61. No abstract available. — View Citation
Li G, Yu Y, Fan Y, Li C, Xu X, Duan J, Li R, Kang X, Ma X, Chen X, Ke Y, Yan J, Lian Y, Liu P, Zhao Y, Zhao H, Chen Y, Sun X, Liu J, Qiao J, Liu J. Genome wide abnormal DNA methylome of human blastocyst in assisted reproductive technology. J Genet Genomic — View Citation
Rubio C, Bellver J, Rodrigo L, Castillon G, Guillen A, Vidal C, Giles J, Ferrando M, Cabanillas S, Remohi J, Pellicer A, Simon C. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, contro — View Citation
Sacchi L, Albani E, Cesana A, Smeraldi A, Parini V, Fabiani M, Poli M, Capalbo A, Levi-Setti PE. Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cu — View Citation
Schieve LA, Meikle SF, Peterson HB, Jeng G, Burnett NM, Wilcox LS. Does assisted hatching pose a risk for monozygotic twinning in pregnancies conceived through in vitro fertilization? Fertil Steril. 2000 Aug;74(2):288-94. doi: 10.1016/s0015-0282(00)00602- — View Citation
Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013 Mar;14(3):204-20. doi: 10.1038/nrg3354. Epub 2013 Feb 12. — View Citation
Yan J, Qin Y, Zhao H, Sun Y, Gong F, Li R, Sun X, Ling X, Li H, Hao C, Tan J, Yang J, Zhu Y, Liu F, Chen D, Wei D, Lu J, Ni T, Zhou W, Wu K, Gao Y, Shi Y, Lu Y, Zhang T, Wu W, Ma X, Ma H, Fu J, Zhang J, Meng Q, Zhang H, Legro RS, Chen ZJ. Live Birth with — View Citation
* Note: There are 14 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | live birth rate of initial embryo transfer | Live birth rate is defined as delivery of any viable infant at 28 weeks or more of gestation, after initial embryo transfer in women using the embryos selected through PIMS or PGT-A or morphological criteria alone. | 22 months | |
Secondary | Good Birth Outcome rate | Defined as a live birth of an infant born at = 37 weeks, with a birth weigh between 2500 and 4000g and without a major congenital anomaly | 36 months | |
Secondary | Clinical pregnancy rate | Twenty days after conception, transvaginal ultrasonography will be performed. Clinical pregnancy will be diagnosed with detection of an intrauterine gestational sac. | 36 months | |
Secondary | Pregnancy loss rate | Number of pregnancy losses / number of clinical pregnancies after transfer. | 36 months | |
Secondary | Multiple pregnancy rate | Number of multiple pregnancy/number of clinical pregnancies after transfer. | 36 months | |
Secondary | Duration of pregnancy | Duration of pregnancy is the period between conception and birth. | 36 months | |
Secondary | Birth weight | Weight of newborns at delivery. | 36 months | |
Secondary | Maternal complications | Number of pregnancies with complications / number of pregnancies. | 48 months | |
Secondary | Neonatal complications | Number of live births with neonatal complications / number of live births. | 48 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03642574 -
Preimplantation DNA Methylation Test (PIMT) in ART
|
N/A | |
Completed |
NCT03787849 -
Epigenetics in PostOperative Pediatric Emergence Delirium
|
N/A | |
Recruiting |
NCT05624827 -
The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)
|
N/A | |
Completed |
NCT05085847 -
Effects of Mindfulness-based Intervention on Epigenetic Mechanisms, Cognition Function, Stress Response, and Well-being
|
N/A | |
Recruiting |
NCT04646954 -
DNA Methylation Testing for the Screening of Uterine Cervical Lesion
|
Phase 3 | |
Recruiting |
NCT04651946 -
Cell-free DNA Methylation for Epithelial Ovarian Cancer
|
Phase 2 | |
Recruiting |
NCT03961191 -
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
|
||
Not yet recruiting |
NCT05779904 -
Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of Stunted Children
|
||
Recruiting |
NCT05791149 -
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
|
N/A | |
Recruiting |
NCT05801263 -
ctDNA Methylation for Epithelial Ovarian Cancer
|
||
Recruiting |
NCT05801276 -
ctDNA Methylation for Detecting Ovarian Cancer
|
||
Recruiting |
NCT05290415 -
Host DNA Methylation for Endometrial Cancer Screening
|
||
Recruiting |
NCT05290922 -
DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening
|
||
Recruiting |
NCT05290428 -
DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening
|
||
Recruiting |
NCT03960879 -
DNA Methylation for Screening Uterine Cervical Lesions
|
||
Recruiting |
NCT05737953 -
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
|
||
Recruiting |
NCT06140992 -
PaCIFiC-CUP Classifies Cancer of Unknown Primary
|
||
Completed |
NCT02032628 -
DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise
|
N/A | |
Completed |
NCT04568512 -
DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture
|
N/A | |
Completed |
NCT03227003 -
DNA Methylation and 1-C Metabolism Nutrient Intake
|
N/A |